Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1632 results

Procedural volume and outcomes for transcatheter aortic-valve replacement

10 Jul 2019

The aim of the study was to evaluate the relationship between volume of TAVR procedures and 30-day outcomes, to determine the persistence of a volume–outcome association...

Luigi Biasco

Reviewer

Luigi Biasco
Procedural volume and outcomes for transcatheter aortic-valve replacement

Challenges with re-accessing the coronaries after TAVI

In this short video Guiseppe Tarantini (Italy) summarises some of the challenges associated with repeat coronary angiography and percutaneous coronary intervention (PCI) after transcatheter aortic valve implantation (TAVI). What is the prevalence of coronary artery disease in patients who have undergone TAVI? What proportion of patients...

Re-accessing coronaries

Imaging

06 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover a selection of challenging cases (migrated DES, repeated unstable angina and TAVI without pre-BAV), and learn more about the perspectives of optical frequency domain imaging and IVUS.

Imaging

TAVI in a bicuspid aortic valve stenosis

05 Jul 2019 – From AICT-AsiaPCR 2019

Watch this LIVE demonstration from Clinique Pasteur (France) to learn about the case of a 81 years-old male patient with dyslipidemia referred to the hospital because of NYHA II shortness of breath related to a severe aortic stenosis. CT scan revealed a type I L-R bicuspid...

TAVI in a bicuspid aortic valve stenosis

The most common TAVI complications

05 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to learn how the most common complications of TAVI happen (annular rupture, coronary occlusion, severe aortic regurgitation...), how to manage them and how to prevent them.

The most common TAVI complications

All you need to know about physiology

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to gain an update on physiology assessment options, learn more about how to correctly perform, interpret and implement physiology based assessments, and discover all about the future perspectives in this field.

All you need to know about physiology

Structural intervention

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover challenging TAVR and other structural interventions cases, such as a cardiac catheter retrieval during a posterior descending artery closure in a 3-year-old baby, a post-TAVR cardiovascular collapse, and more!

Structural intervention

Evolving indications for TAVI: a PCR statement

03 Jul 2019 – From EuroPCR 2019

What are the evolving indications for transcatheter aortic valve implementation (TAVI) in severe aortic valve stenosis? Stephan Windecker discusses a PCR statement with William Wijns that suggests a “shift in paradigm” in terms of treating patients with this condition. Learn more about the evidence from randomised...

TAVI low-risk trials - EuroPCR 2019

EuroPCR 2019: Highlights of Interventions for Valvular Disease

Martine Gilard (France), Philip MacCarthy (UK) and Michael Lee (Hong Kong) discuss what’s new at EuroPCR 2019 to meet the demands of a rapidly expanding population: simplifying the technique and minimising the risk to the patient, acknowledging the huge expansion of mitral edge-to-edge repair and the...

Highlights of Interventions for Valvular Disease - EuroPCR 2019

TAVI and stroke prevention

Systematic imaging has shown silent injury to the brain in the vast majority of TAVI patients. Jean-Philippe Collet (France) asks Alexandra Lansky (USA and UK) about the incidence, risk factors and protection in periprocedural stroke. From explaining the mechanical causes and the rates of clinical and...

TAVI and stroke prevention

TAVI and stroke prevention

24 May 2019 – From EuroPCR 2019

Consult this session to learn all about how to prevent stroke during TAVI, especially in patients at high risk for cerebral embolism or with atrial fibrillation, through cerebral protection devices, anticoagulation, LAA closure, and more!

TAVI and stroke prevention

Major TAVI complication (annulus rupture, valve embolisation, incomplete frame expansion)

24 May 2019 – From EuroPCR 2019

Consult this session on major TAVI complications to learn through compelling clinical cases all about how to manage and avoid complications, such as annulus rupture, valve embolisation, incomplete frame expansion, and more!

Major TAVI complication (annulus rupture, valve embolisation, incomplete frame expansion)

Advanced TAVI: challenges and complexities in TAVI 2019 in high-risk patients

24 May 2019 – From EuroPCR 2019

Consult this session on advanced TAVI to discover all about the challenges and complexities in TAVI 2019 in high-risk patients with difficult anatomies, and how to prevent and overcome them.

Advanced TAVI: challenges and complexities in TAVI 2019 in high-risk patients

New embolic protection device wins Jon DeHaan Foundation Award

William Wijns and Robert Schwartz talk to this year’s Jon DeHaan Foundation Award winner, Giora Weisz, from the Montefiore Medical Center in New York, about his winning embolic protection device for use in TAVI procedures. The award is presented for the best interventional technology project to...

Jon DeHaan Foundation Award - Innovators Day

Latest developments in cerebral embolic protection

23 May 2019 – From EuroPCR 2019

Consult this session to hear the latest update on the US REFLECT phase II trial, to learn about the EU experience with the TriGUARD 3 CEP device and to learn about Keystone Heart's EU roadmap.

Latest developments in cerebral embolic protection

Innovations in TAVI: new valves, new procedures

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the innovations in TAVI from 2019, regarding valves and procedures, such as AorticLab system, FACTA technology, and more!

Innovations in TAVI: new valves, new procedures

TAVI outcomes outside the cathlab – Importance of haemodynamics and durability

23 May 2019 – From EuroPCR 2019

Watch this LIVE case to learn more on TAVI in failed surgical aortic bioprosthesis, how to minimise risk of patient-prosthesis mismatch and coronary protection.

A 91-year-old female with an active lifestyle underwent a surgical aortic valve replacement 15 years ago. She presents with NYHA III and CCS...

TAVI outcomes outside the cathlab – Importance of haemodynamics and durability

Machine learning, artificial intelligence, e-health: application for percutaneous intervention

23 May 2019 – From EuroPCR 2019

Consult this session on machine learning and artificial intelligence and discover their applications during percutaneous intervention thanks to various compelling clinical cases.

Machine learning, artificial intelligence, e-health: application for percutaneous intervention

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

23 May 2019 – From EuroPCR 2019

Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

Management of coronary complications after TAVI

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to manage coronary complications after TAVI, such as left main coronary obstruction, cardiovascular collapse, and more!

Management of coronary complications after TAVI